FibroBiologics General Counsel Buys 40,000 Shares

Insider purchase represents 28.57% increase in ownership stake

Mar. 3, 2026 at 5:47am

Got story updates? Submit your updates here. ›

FibroBiologics Inc. (NASDAQ:FBLG) General Counsel Ruben Garcia purchased 40,000 shares of the company's stock on February 27th, 2026. The shares were bought at an average price of $0.33 per share, for a total value of $13,200. Following the acquisition, Garcia now directly owns 180,000 shares in the company, valued at $59,400.

Why it matters

Insider buying can be a positive signal for investors, as it suggests company insiders believe the stock is undervalued and have confidence in the company's future prospects. FibroBiologics is a small-cap biotech company, and insider purchases of this size can be meaningful for a company of its size.

The details

Garcia's purchase represents a 28.57% increase in his ownership stake in FibroBiologics. The company's stock has traded between $0.22 and $1.53 over the past 52 weeks, with a current market cap of $28.36 million. FibroBiologics is developing a pipeline of cell therapy and regenerative medicine treatments for various chronic diseases.

  • The transaction occurred on Friday, February 27th, 2026.

The players

Ruben Garcia

General Counsel of FibroBiologics Inc.

FibroBiologics Inc.

A cell therapy and regenerative medicine company developing treatments for chronic diseases.

Got photos? Submit your photos here. ›

The takeaway

The insider purchase by FibroBiologics' General Counsel suggests he believes the company's stock is undervalued and has confidence in its future prospects. Insider buying can be a positive signal for investors, especially for a small-cap biotech company like FibroBiologics.